Skip to main content

Kyntra Bio, Inc.

KYNB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000921299

No open-market purchases or sales by Kyntra Bio, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $7.54M in total; no superinvestor holds it.

13F holders, Q2 2023

Institutional positions in Kyntra Bio, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
153
−20 vs. Q1 2023
Shares held
76.4M
+48.3K (+0.1%) vs. Q1 2023
Total value
$207.9M
−$1.22B (−85.4%) vs. Q1 2023
New holders
30
56 more added
Sold out
50
49 more reduced

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting KYNB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 153 institutions
Q1 2021: 199 institutionsQ2 2021: 176 institutionsQ3 2021: 165 institutionsQ4 2021: 164 institutionsQ1 2022: 158 institutionsQ2 2022: 152 institutionsQ3 2022: 152 institutionsQ4 2022: 145 institutionsQ1 2023: 173 institutionsQ2 2023: 153 institutionsQ3 2023: 110 institutionsQ4 2023: 100 institutionsQ1 2024: 111 institutionsQ2 2024: 102 institutionsQ3 2024: 72 institutionsQ4 2024: 70 institutionsQ1 2025: 56 institutionsQ2 2025: 30 institutionsQ3 2025: 32 institutionsQ4 2025: 34 institutionsQ1 2026: 32 institutionsQ2 2026: 27 institutions
Value heldQ2 2023: $207.9M
Q1 2021: $2.47BQ2 2021: $1.80BQ3 2021: $656.8MQ4 2021: $934.6MQ1 2022: $816.6MQ2 2022: $746.9MQ3 2022: $950.1MQ4 2022: $1.20BQ1 2023: $1.42BQ2 2023: $207.9MQ3 2023: $59.0MQ4 2023: $62.1MQ1 2024: $143.9MQ2 2024: $50.4MQ3 2024: $18.3MQ4 2024: $19.2MQ1 2025: $10.2MQ2 2025: $5.62MQ3 2025: $13.9MQ4 2025: $10.1MQ1 2026: $7.01MQ2 2026: $7.54M
Institutions holding KYNB and their total value by quarter
QuarterHoldersValue
Q2 202627$7.54M
Q1 202632$7.01M
Q4 202534$10.1M
Q3 202532$13.9M
Q2 202530$5.62M
Q1 202556$10.2M
Q4 202470$19.2M
Q3 202472$18.3M
Q2 2024102$50.4M
Q1 2024111$143.9M
Q4 2023100$62.1M
Q3 2023110$59.0M
Q2 2023153$207.9M
Q1 2023173$1.42B
Q4 2022145$1.20B
Q3 2022152$950.1M
Q2 2022152$746.9M
Q1 2022158$816.6M
Q4 2021164$934.6M
Q3 2021165$656.8M
Q2 2021176$1.80B
Q1 2021199$2.47B

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding Kyntra Bio, Inc.; share changes are against Q1 2023.

Institutions holding KYNB in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Quadrant Capital Group LLC0$00.00%−418−100.0%Sold out
Signaturefd, LLC0$00.00%−206−100.0%Sold out
Institutional & Family Asset Management, LLC0$00.00%−24−100.0%Sold out